NCS Healthcare of Kentucky Inc FDA Recalls

2 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product	Reason	Class	Initiated
Lisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count blister card (NDC 061Class IIIOct 27, 2023Presence of Foreign Tablets: Potential of stray tablet(s) of	Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recal	Class IIIDrugs	Oct 27, 2023
Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister cardClass IIIOct 27, 2023Presence of Foreign Tablets: Potential of stray tablet(s) of	Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recal	Class IIIDrugs	Oct 27, 2023